Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response

Advanced search
Browse by:

Department | Year

UCL Theses | Latest

Deposit your research

Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response

Haller, S; Barkhof, F; Thomas, D; Lovblad, K-O; Golay, X; Zaharchuk, G; (2017) Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response. Radiology , 284 (1) pp. 302-303. 10.1148/radiol.2017170252. Green open access

[thumbnail of Golay_Haller Rad17-0252 ResponseHYK Edits_SH2-FINAL.pdf]

Preview

Text
Golay_Haller Rad17-0252 ResponseHYK Edits_SH2-FINAL.pdf - Accepted Version
Download (85kB) | Preview

Type:	Article
Title:	Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan Response
Open access status:	An open access version is available from UCL Discovery
DOI:	10.1148/radiol.2017170252
Publisher version:	https://doi.org/10.1148/radiol.2017170252
Language:	English
Additional information:	This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification:	UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Brain Repair and Rehabilitation
URI:	https://discovery-pp.ucl.ac.uk/id/eprint/1562185

Downloads since deposit

8,360Downloads

Download activity - last month

Download activity - last 12 months

Downloads by country - last 12 months

Archive Staff Only

View Item